- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +91 more
- Locations
-
- Chedoke-McMaster Hospitals Hamilton, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
- Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
Clinical trial condition
Nodal Marginal Zone B-cell Lymphoma
Explore clinical trials studying Nodal Marginal Zone B-cell Lymphoma. Study availability and eligibility vary by location and protocol.
83 public trials
0 recruiting studies
Nodal Marginal Zone B-cell Lymphoma trial results
NCT00621452
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +38 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00110071
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +46 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma
NCT00054639
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +60 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00290472
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Burkitt Lymphoma, +54 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States
- Evanston Hospital CCOP Evanston, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States
NCT01233921
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
NCT00890747
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
- Locations
-
- Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
- Northwestern University Chicago, Illinois, United States
- AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
NCT00499811
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- National Institutes of Health Bethesda, Maryland, United States
NCT00458731
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +116 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00769288
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +107 more
- Locations
-
- Wayne State University Detroit, Michigan, United States